Mission
Our mission is to improve healthcare by developing novel catheter-based medical devices for minimally invasive delivery to the blood vessels in the brain, for the treatment of ANEUrysms, stroke, and other VAScular defects. (ANEUVAS) Aneuvas Technologies, Inc. (ATI), established in 2013 and headquartered in Flagstaff, Arizona, is a pioneering start-up dedicated to advancing healthcare. ATI specializes in developing innovative medical devices delivered with a catheter for minimally invasive treatment of brain aneurysms and strokes through precise delivery via the blood vessels. Currently, ATI holds four novel patents for devices that provide better biocompatibility and post-treatment outcomes of neurological defects.
Meet the Team
Brent Vernon
Co-Founder and Chief Science Officer
Brent is a pioneer in smart polymer systems for medical applications, bringing decades of research expertise to the forefront of biomedical innovation. As a professor of biomedical engineering at Northern Arizona University, he has translated cutting-edge science into real-world solutions through the founding of multiple biotech companies.
Mark Preul
Co-Founder and Managing Director
Mark is an expert in medical device development with extensive experience in neurosurgery research. He serves as the Director of Neurosurgery Research at Barrow Neurological Institute, where he mentors the next generation of neurosurgeons through hands-on training of residents and fellows.
Tim Becker, PH.D
Chief Technical Officer
Tim has spent over two decades at the forefront of neurovascular device development, bringing deep technical and clinical insight to every stage of the design process. He has successfully navigated a device from concept to acquisition, giving him firsthand understanding of what it takes to build technology that earns the trust of both surgeons and strategic partners. As a professor at Northern Arizona University, Tim has spent more than a decade mentoring the next generation of medical device engineers — a commitment that reflects both his passion for the field and his investment in its future.
Andrew Ducruet, PH.D
Chief Medical Officer
Andrew is a neurointerventional surgeon with over 20 years of experience in stroke treatment and care. As Principal Investigator of stroke research at Barrow Neurological Institute, one of the world’s leading neuroscience centers, he brings both frontline clinical expertise and rigorous research experience to the team.
William Merritt, PH.D
Vice President, R&D
William’s doctoral research was dedicated to optimizing NeuroCURE for use in occluding aneurysms, giving him an unmatched depth of knowledge in the core technology behind Aneuvas. He has since gone on to found multiple biotech companies and plays an active role in building the regulatory infrastructure for regenerative medicine.